Tests:Lipids: Difference between revisions

Tests:Lipids
Created page with "{{DISPLAYTITLE: Lipids}} Full Test List Biochemistry Tests {| class="wikitable" ! colspan="2" | === Overview === |- |Department |Biochemistry  |- |Test Code |LIPS |- |Synonyms |Cholesterol HDL Cholesterol LDL Cholesterol Triglyceride.  |- |Turnaround Time |2 hours  |- |Stability – Add test | |- ! colspan="2" | === Specimen Requirements === |- |Specimen Type |Serum Plasma |- |Specimen Transportation | |- |Preferred |6 mL Plain <span style="backgro..."
 
No edit summary
Line 4: Line 4:
{| class="wikitable"
{| class="wikitable"
! colspan="2" |
! colspan="2" |
=== Overview ===
== Overview ==
|-
|-
|Department
|Department
Line 11: Line 11:
|Test Code
|Test Code
|LIPS
|LIPS
|-
|Constituent Tests
|Cholesterol, Plasma
Triglyceride, Plasma
Cholesterol LDL (Calculated), Plasma
HDL Cholesterol, Plasma
Cholesterol/HDL Ratio, Plasma
|-
|Test Availabilty
|Monday - Sunday, testing routinely available out of hours
|-
|-
|Synonyms
|Synonyms
Line 19: Line 33:
LDL Cholesterol
LDL Cholesterol


Triglyceride. 
Triglyceride  
|-
|-
|Turnaround Time
|Turnaround Time
Line 25: Line 39:
|-
|-
|Stability – Add test
|Stability – Add test
|
|24 hours
|-
|-
! colspan="2" |
! colspan="2" |
=== Specimen Requirements ===
== Specimen Requirements ==
|-
|-
|Specimen Type
|Specimen Type
Line 34: Line 48:


Plasma
Plasma
|-
|Specimen Transportation
|
|-
|-
|Preferred
|Preferred
Line 43: Line 54:
|Acceptable
|Acceptable
|4 mL Li-Hep <span style="background:#3cb371"> Green-Top </span>     
|4 mL Li-Hep <span style="background:#3cb371"> Green-Top </span>     
|-
|Unacceptable
|
|-
|Specimen Transportation
|
|-
|-
|Paediatric Requirements   
|Paediatric Requirements   
Line 48: Line 65:
|-
|-
! colspan="2" |
! colspan="2" |
=== ''Aliquot Requirements'' ===
== Aliquot Requirements ==
|-
|-
|Sample Type
|Sample Type
|
|-
|Preferred Volume
|
|
|-
|-
Line 60: Line 80:
|-
|-
! colspan="2" |
! colspan="2" |
=== ''Clinical Information'' ===
== Clinical Information ==
|-
|-
|Reference Intervals
|Reference Intervals
Line 67: Line 87:
Reported Comments:  
Reported Comments:  


1. All reports get this comment (see below for additional information on optimal levels):  
1. ''All reports get this comment'' ''(see below for additional information on optimal levels):''


"Optimal levels are suggested by the New Zealand Guidelines Group though an individualised multi-factorial approach is preferred."  
"Optimal levels are suggested by the New Zealand Guidelines Group though an individualised multi-factorial approach is preferred."  


2. All reports get this comment, unless superseded by any one or more of the other comments below:  
2. ''All reports get this comment, unless superseded by any one or more of the other comments below:''


"Cardiovascular risk should be addressed by lifestyle and pharmacological interventions in subjects with 5-year CV risk  
"Cardiovascular risk should be addressed by lifestyle and pharmacological interventions in subjects with 5-year CV risk  


greater than 15%."
greater than 15%."
Line 86: Line 106:
|Not required
|Not required
|-
|-
| colspan="2" |Comments
! colspan="2" |
== Comments ==
|-
|-
| colspan="2" |The calculation of LDL Cholesterol is only an approximation and is invalid in the presence of VLDL, Therefore LDL Cholesterol is calculated only if the triglycerides are less than 4.5 mmol/L.   
| colspan="2" |The calculation of LDL Cholesterol is only an approximation and is invalid in the presence of VLDL, Therefore LDL Cholesterol is calculated only if the triglycerides are less than 4.5 mmol/L.